CAS 341031-54-7: Sunitinib malate
Description:Sunitinib malate is a small molecule tyrosine kinase inhibitor primarily used in the treatment of certain types of cancer, including renal cell carcinoma and gastrointestinal stromal tumors. It functions by inhibiting multiple receptor tyrosine kinases, which are involved in tumor growth and angiogenesis. The substance appears as a yellow to orange crystalline powder and is soluble in organic solvents like dimethyl sulfoxide (DMSO) and methanol, but has limited solubility in water. Its molecular formula reflects a complex structure that includes a pyrrole ring and a substituted phenyl group, contributing to its pharmacological activity. Sunitinib malate is administered orally and is known for its side effects, which can include fatigue, diarrhea, and hypertension, among others. The malate salt form enhances its stability and bioavailability. As a targeted therapy, it represents a significant advancement in cancer treatment, focusing on inhibiting specific pathways that promote tumor growth rather than broadly affecting all rapidly dividing cells.
Formula:C22H27FN4O2·C4H6O5
InChI:InChI=1/C23H30N4O2.C5H8O5/c1-6-27(7-2)11-10-24-23(29)21-15(4)20(25-16(21)5)13-18-17-12-14(3)8-9-19(17)26-22(18)28;6-3(5(9)10)1-2-4(7)8/h8-9,12-13,25H,6-7,10-11H2,1-5H3,(H,24,29)(H,26,28);3,6H,1-2H2,(H,7,8)(H,9,10)/b18-13-;/t;3-/m.0/s1
SMILES:O=C(O)CC(O)C(=O)O.O=C1NC2=CC=C(F)C=C2C1=CC=3NC(=C(C(=O)NCCN(CC)CC)C3C)C
- Synonyms:
- (2S)-2-hydroxybutanedioic acid - N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (1:1)
- 1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)- (5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4- dimethyl-, (2S)-hydroxybutanedioate (1:1)
- 2-hydroxypentanedioic acid - N-[2-(diethylamino)ethyl]-2,4-dimethyl-5-[(Z)-(5-methyl-2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-1H-pyrrole-3-carboxamide (1:1)
- Butanedioic acid, 2-hydroxy-, (2S)-, compd. with N-[2-(diethylamino)ethyl]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide (1:1)
- Butanedioic acid, hydroxy-, (2S)-, compd. with N-(2- (diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H- indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3- carboxamide (1:1)
- N-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide (2S)-hydroxybutanedioate
- Su 011248
- Su 11248
- Sunitinib <span class="text-smallcaps">L</span>-malate
- Sunitinib L-malate
- See more synonyms
- Sunitinib Mablate
- Sunitinib Maleate
- Sutent
- Sunitinib malate